Larvol Delta - Evaluate-the-Safety-and-Immunogenicity-of-a-9valent-HPV-Vaccine-in-Chinese-Healthy-Male-Aged-945-Yearold

9-valent human papillomavirus recombinant vaccine - Shanghai Bovax Biotech

http://clinicaltrials.gov/ct2/show/NCT05518201

Oct 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next